Product Reports Resources Pricing Login Book a demo

Fate Therapeutics

Biotech & Life Sciences · San Diego, United States · Founded 2007 · IPO 2013

Stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics

Valuation $187M
Revenue $5.2M
Power Law Unicorn$1–10B valuation tier

Talent graph

Fate Therapeutics's talent

Book a demo to see the people
Employees mapped 229 incl. 1 AI specialist
Founders Hidden — book a demo/100 quality score
Key operators 23 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 7 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

11 investors on Fate Therapeutics's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 4 investors entered at this stage
Venrock
Polaris Partners
OVP Venture Partners
ARCH Venture Partners
Series B+ 7 investors entered at this stage
Children’s Hospital Boston
Harvard University
Scripps Translational Science Institute
Massachusetts General Hospital
Astellas Venture
University of Washington
Stanford University

Fate Therapeutics mafia

Startups founded by Fate Therapeutics alumni

Former Fate Therapeutics employees who went on to start their own companies. Sorted by Dealroom signal score.

Scholar RockEst. 2012
Leonard ZonUnited States
Signal score93
Vivace TherapeuticsEst. 2014
Sheng DingUnited States
Signal score82
Artiva BiotherapeuticsEst. 2019
Peter FlynnUnited States
Signal score78
Syros PharmaceuticalsEst. 2012
Alex RivesUnited States
Signal score70
Clear Creek BioEst. 2017
David ScaddenUnited States
Signal score68
ReceptosEst. 2009
WRWilliam RastetterUnited States
Signal score61
PellePharmEst. 2012
PBPhillip BeachyUnited States
Signal score59

Book a demo to explore the full alumni network →

Global footprint

Where Fate Therapeutics has talent and traffic

Workforce by country
3 countries with
team presence
🇺🇸 United States98.8%
🇨🇳 China0.6%
🇪🇸 Spain0.6%
3 countries shown
Web traffic by country
10K monthly visits
across markets
🇺🇸 United States64%
🏳️ Korea12%
🏳️ Republic of8%
🇮🇳 India6%
🇯🇵 Japan6%
Top 5 markets shown

Patent intelligence

Fate Therapeutics’s patent portfolio

Estimated portfolio value
$55M

48 active families in the valuation dataset.

Source: Dealroom Patent Intelligence · PatSnap. Portfolio estimates and the family records below have different coverage.

Compare patent portfolios across companies →

Market sentiment

What the market is saying about Fate Therapeutics

An AI-synthesized read of the highest-engagement posts about Fate Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Fate Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles